The FDA has cleared Dignitana to conduct a final clinical study of DigniCap in stage I or II breast cancer patients. The device, designed to help prevent hair loss in patients undergoing chemotherapy, features an inner cap and an outer cap linked to a refrigeration and control unit with touch-screen controls to track scalp temperature and administer cooling liquid.

Full Story:

Related Summaries